Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Martin Snajdauf"'
Autor:
Martin Snajdauf, Klara Havlova, Jiri Vachtenheim, Andrej Ozaniak, Robert Lischke, Jirina Bartunkova, Daniel Smrz, Zuzana Strizova
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
TRAIL (tumor-necrosis factor related apoptosis-inducing ligand, CD253) and its death receptors TRAIL-R1 and TRAIL-R2 selectively trigger the apoptotic cell death in tumor cells. For that reason, TRAIL has been extensively studied as a target of cance
Externí odkaz:
https://doaj.org/article/fbf946f47c644b1e884e13dae81ac836
Autor:
Robert Lischke, A. Stolz, Tomas Harustiak, Hana Faltova, Alexandr Pazdro, Martin Snajdauf, Pavel Fencl, Milada Zemanova
Publikováno v:
Neoplasma. 68:423-433
We prospectively investigated whether metabolic response assessed by 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography (PET/CT) early in the course of neoadjuvant chemotherapy is predictive of survival in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf90d91c6d03debb110fcf8091e8cf86
https://doi.org/10.4149/neo_2020_200815n863
https://doi.org/10.4149/neo_2020_200815n863
Autor:
Zuzana Strizova, Jiri Vachtenheim, Martin Snajdauf, Robert Lischke, Jirina Bartunkova, Daniel Smrz
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
In a limited number of human malignancies, anti-CD47 therapy leads to the rapid clearance of tumor cells by macrophages. In esophageal squamous cell carcinoma, anti-CD47 treatment has shown promising results in vitro. However, the CD47 expression pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::782d24ecf0c40207a5c3f629ea2aaaf7
http://link.springer.com/article/10.1038/s41598-020-70771-y
http://link.springer.com/article/10.1038/s41598-020-70771-y
Autor:
Kristina Hugova, Martin Snajdauf, Tomas Harustiak, Zuzana Vackova, Julius Spicak, Jan Martinek, Jana Krajciova, Marek Kollar, Alexandr Pazdro, Jana Maluskova
Publikováno v:
Diseases of the Esophagus. 34
Esophagectomy is a standard of care for patients with "high-risk" early esophageal cancer (HRC) despite a growing evidence that endoscopic treatment may be a safe alternative. Our aims were 1. to prospectively evaluate the long-term results of endosc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff6a2feb42b3d75cdd2149a4f6e57dcf
https://doi.org/10.1093/dote/doab052.305
https://doi.org/10.1093/dote/doab052.305
Publikováno v:
Diseases of the Esophagus. 34
Anastomotic leak (AL) and conduit necrosis (CN) are among the most serious surgical complications after esophageal resection. Endoscopic, radiological and surgical methods are used in their treatment. The aim of this paper is to evaluate the results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30badb75f6b2ccf27bfa31aea011103c
https://doi.org/10.1093/dote/doab052.544
https://doi.org/10.1093/dote/doab052.544
Autor:
Andrej Ozaniak, Jirina Bartunkova, Klara Havlova, Martin Snajdauf, Daniel Smrz, Jiri Vachtenheim, Zuzana Strizova, Robert Lischke
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences
TRAIL (tumor-necrosis factor related apoptosis-inducing ligand, CD253) and its death receptors TRAIL-R1 and TRAIL-R2 selectively trigger the apoptotic cell death in tumor cells. For that reason, TRAIL has been extensively studied as a target of cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a68f975bdcb31f8ba710f378228f00
https://www.frontiersin.org/articles/10.3389/fmolb.2021.628332/full
https://www.frontiersin.org/articles/10.3389/fmolb.2021.628332/full
Autor:
Kristina Hugova, Marek Kollar, Tomas Harustiak, Martin Snajdauf, Alexandr Pazdro, Daniela Kodetova, Zuzana Vackova, Julius Spicak, Jan Martinek
Publikováno v:
Gastroenterology. 162:S-549
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2584fe546b5a6e6ef161b9a0e50e6a6a
https://doi.org/10.1016/s0016-5085(22)61303-9
https://doi.org/10.1016/s0016-5085(22)61303-9
Autor:
Daniel Smrz, Zuzana Strizova, Jan Biskup, Jirina Bartunkova, Martin Snajdauf, Robert Lischke, Jiri Vachtenheim, Dmitry Stakheev, Pavla Taborska
Publikováno v:
Journal of cancer research and clinical oncology. 146(8)
Esophageal cancer (EC) is one of the most lethal gastrointestinal malignancies. Immunotherapy is a promising treatment modality for this disease. However, broader implementation of EC immunotherapy has been discouraged because of insufficient underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae56a9fff748acedf1c5ae9912a60cb3
https://pubmed.ncbi.nlm.nih.gov/32447483
https://pubmed.ncbi.nlm.nih.gov/32447483
Autor:
Milada Zemanova, A. Stolz, Ludmila Hornofova, P. Fencl, E. Salkova, Robert Lischke, Alexandr Pazdro, Tomas Harustiak, Martin Snajdauf
Publikováno v:
British Journal of Surgery. 105:419-428
Background The aim of this prospective study was to assess whether [18F]fluorodeoxyglucose PET can be used to predict histopathological response early in the course of neoadjuvant chemotherapy in patients with adenocarcinoma of the oesophagus and oes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::921e32cd37ae4d6a046b30a8c648d342
https://doi.org/10.1002/bjs.10712
https://doi.org/10.1002/bjs.10712
Autor:
Julius Spicak, Marek Kollar, Zuzana Vackova, Jan Martinek, Alexandr Pazdro, Jana Krajciova, Tomas Harustiak, Jana Maluskova, Martin Snajdauf, Kristina Ottavova
Publikováno v:
Gastroenterology. 158:S-845
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ac3c9e9ce7677cedd9a4e409b4c7b86
https://doi.org/10.1016/s0016-5085(20)32792-x
https://doi.org/10.1016/s0016-5085(20)32792-x